In her most recent article for the University of Cincinnati Law Review Blog, Associate Member Emmaline Fisher discusses the issue of inventorship for AI-generated works.
Patents and AI-Generated Works: Should AI Be Designated as Inventors?
Patent Evergreening and the Response by the USPTO and FDA
In her most recent blog post, Associate Member Emmaline Fisher discusses patent evergreening, its effects on prescription drug prices, and the USPTO’s and the FDA’s response to President Biden’s Executive Order that this issue be addressed and fixed.